Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - OPERATING EXPENSES
Operating Expenses EYPT - EyePoint Pharmaceuticals, Inc.
115 M
LAST VALUE
17.00%
2 YEAR CAGR
31.52%
5 YEAR CAGR
23.29%
10 YEAR CAGR